Published in Immun Ageing on July 08, 2013
Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis. PLoS One (2015) 1.39
Critical role of calpain in inflammation. Biomed Rep (2016) 0.75
Roles of calpain-calpastatin system (CCS) in human T cell activation. Oncotarget (2016) 0.75
The calpain system. Physiol Rev (2003) 9.95
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Calpain and caspase: can you tell the difference? Trends Neurosci (2000) 3.14
Regulating cell migration: calpains make the cut. J Cell Sci (2005) 3.03
Structure and physiological function of calpains. Biochem J (1997) 2.62
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Down-regulation of CD28 expression by TNF-alpha. J Immunol (2001) 1.65
Regulation of cyclin D1 by calpain protease. J Biol Chem (1997) 1.36
Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J Biol Chem (2006) 1.25
Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol (2004) 1.24
Calpain chronicle--an enzyme family under multidisciplinary characterization. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.21
Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div (2006) 1.13
Aging, immunity, and cancer. Discov Med (2011) 1.11
Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J Immunol (2004) 1.10
Calpain 2 controls turnover of LFA-1 adhesions on migrating T lymphocytes. PLoS One (2010) 1.08
Calpains as potential anti-cancer targets. Expert Opin Ther Targets (2011) 1.05
The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition. J Mol Biol (2006) 1.01
Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2011) 0.97
Participation of the conventional calpains in apoptosis. Biochim Biophys Acta (2002) 0.97
Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. J Immunol (1999) 0.95
Genetics of longevity. data from the studies on Sicilian centenarians. Immun Ageing (2012) 0.95
Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood (2002) 0.93
Paradoxical age-related cell cycle quickening of human CD4(+) lymphocytes: a role for cyclin D1 and calpain. Exp Gerontol (2004) 0.91
Conventional calpains and programmed cell death. Acta Biochim Pol (2011) 0.89
Calpastatin subdomains A and C are activators of calpain. J Biol Chem (2002) 0.88
Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun Ageing (2012) 0.87
The role of T cells in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz) (2000) 0.87
Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain. Immun Ageing (2005) 0.83
Signal transduction changes in granulocytes and lymphocytes with ageing. Immunol Lett (1994) 0.83
Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis. Hum Immunol (2012) 0.82
Cytotoxic CD4+CD28 null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease. Nephron Clin Pract (2012) 0.81
Ex vivo measurement of calpain activation in human peripheral blood lymphocytes by detection of immunoreactive products of calpastatin degradation. Folia Histochem Cytobiol (2007) 0.81
Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals. PLoS One (2011) 0.79
Superoxide anion production and intracellular free calcium levels in resting and stimulated polymorphonuclear leukocytes obtained from healthy and arteriosclerotic subjects of various ages. Clin Biochem (1992) 0.77
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Human immunosenescence: is it infectious? Immunol Rev (2005) 2.83
Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev (2006) 2.82
Is immunosenescence infectious? Trends Immunol (2004) 2.47
T cells and aging, January 2002 update. Front Biosci (2002) 2.14
Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005) 1.99
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum (2005) 1.88
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A (2003) 1.65
The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59
Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev (2005) 1.49
Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev (2002) 1.48
Expression of heat shock protein 72 in peritoneal leukocytes is induced by peritoneal dialysis. Perit Dial Int (2007) 1.42
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol (2011) 1.37
Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol (2002) 1.24
Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing (2010) 1.22
Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing (2007) 1.21
A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev (2009) 1.21
Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheimers Dis (2009) 1.20
Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing (2011) 1.19
Mechanisms of immunosenescence. Immun Ageing (2009) 1.19
Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging (2006) 1.17
B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev (2003) 1.17
Immunogenetics, gender, and longevity. Ann N Y Acad Sci (2006) 1.16
Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA (2004) 1.12
Inflammation, ageing and cancer. Mech Ageing Dev (2008) 1.12
Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem (2002) 1.11
TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol (2009) 1.08
Inflammation and life-span. Science (2005) 1.07
Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Artif Organs (2010) 1.07
Inflammation and prostate cancer. Future Oncol (2008) 1.04
Immunity & Ageing: a new journal looking at ageing from an immunological point of view. Immun Ageing (2004) 1.04
Biology of longevity: role of the innate immune system. Rejuvenation Res (2006) 1.03
Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev (2006) 1.03
IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol (2003) 1.01
A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci (2006) 1.01
Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes. Artif Organs (2010) 1.00
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev (2008) 1.00
Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics (2007) 1.00
Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol (2007) 0.99
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother (2005) 0.99
CCR5 receptor: biologic and genetic implications in age-related diseases. Ann N Y Acad Sci (2007) 0.98
B cells and immunosenescence: a focus on IgG+IgD-CD27- (DN) B cells in aged humans. Ageing Res Rev (2010) 0.98
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS One (2010) 0.97
B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology (2011) 0.97
Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J Alzheimers Dis (2010) 0.97
IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev (2003) 0.97
Memory B cell subpopulations in the aged. Rejuvenation Res (2006) 0.96
Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res Rev (2008) 0.96
Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. J Alzheimers Dis (2010) 0.96
Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol (2011) 0.96
Pathophysiology of ageing, longevity and age related diseases. Immun Ageing (2007) 0.96
Genetics of longevity. data from the studies on Sicilian centenarians. Immun Ageing (2012) 0.95
Biomarkes of aging. Front Biosci (Schol Ed) (2010) 0.95
Immune profiling of Alzheimer patients. J Neuroimmunol (2011) 0.94
Zinc and inflammatory/immune response in aging. Ann N Y Acad Sci (2007) 0.94
Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Res (2008) 0.94
Decreased proliferative capability of CD4(+) cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells. Exp Gerontol (2004) 0.94